Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $183.88 Analyst target: $206.66 Upside: 12.39%
AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom.
See the full interactive analysis & chart →Informational only — not investment advice.